Price$4.79-0.21 (-4.30%)
04:00 PM07:30 PM
News · 26 weeks46-33%
2025-12-142026-06-07
Mix2390d
- Insider9(39%)
- SEC Filings8(35%)
- Market6(26%)
Latest news
25 items- NEWSModular Medical Launches New Website for Pivot Tubeless Insulin Patch PumpInitial patients expected in June 2026 SAN DIEGO, CA / ACCESS Newswire / June 4, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery, today announced the launch of PivotPump.com, a patient-focused website designed to support individuals seeking a simpler path to insulin pump therapy.This launch follows the Company's receipt of U.S. Food and Drug Administration ("FDA") clearance in April 2026 for its Pivot™ insulin delivery system. The FDA clearance represents a significant milestone in Modular Medical's strategy to expand access to insulin pump technology, particularly among individuals historically underse
- SECModular Medical Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Modular Medical, Inc. (0001074871) (Filer)
- INSIDERSEC Form 4 filed by Officer Diperna Paul4 - Modular Medical, Inc. (0001074871) (Issuer)
- INSIDERSEC Form 4 filed by Chief Operating Officer Schmid Kevin4 - Modular Medical, Inc. (0001074871) (Issuer)
- SECSEC Form EFFECT filed by Modular Medical Inc.EFFECT - Modular Medical, Inc. (0001074871) (Filer)
- NEWSRegistration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "From FDA Wins to Scaling Manufacturing - What Investors Should Watch." Featuring Modular Medical CEO - Friday, May 1, 2026Meet with Modular Medical CEO Jeb BesserThere are 4.8 million individuals with diabetes in the US that require daily insulin. Only 20% currently use an insulin pump.Discover Modular Medical's Pivot, the first FDA-cleared, two-part tubeless patch pump featuring a removable 3 mL reservoir, disposable battery, smartphone connectivity for bolus and monitoring, and true electronic accuracy without tubes or constant wear and its associated commercial & manufacturing timeline.Register at MODD-May-Watch.TribePublic.com SAN DIEGO, CA / ACCESS Newswire / April 29, 2026 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a leader in innovative, patient-centric insulin delivery,
- SECSEC Form S-3 filed by Modular Medical Inc.S-3 - Modular Medical, Inc. (0001074871) (Filer)
- SECModular Medical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits8-K - Modular Medical, Inc. (0001074871) (Filer)
- SECSEC Form 424B5 filed by Modular Medical Inc.424B5 - Modular Medical, Inc. (0001074871) (Filer)
- NEWSModular Medical Announces Pricing of $3.4 Million Registered Direct Offering of Common StockSAN DIEGO, CA / ACCESS Newswire / April 19, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery, today announced the pricing of a registered direct offering (the "Offering") consisting of 750,000 shares of the Company's common stock at an offering price of $4.50 per share. The gross proceeds to the Company from the Offering are estimated to be approximately $3.4 million before deducting placement agent fees and other offering expenses. The Offering is expected to close on or about April 21, 2026, subject to the satisfaction of customary closing conditions.Maxim Group LLC is acting as the sole placement agen
- SECModular Medical Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Modular Medical, Inc. (0001074871) (Filer)
- NEWSModular Medical Regains Compliance with Nasdaq Minimum Bid Price RequirementSAN DIEGO, CA / ACCESS Newswire / April 16, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery, today announced that it has received a letter from the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it has regained compliance with the Nasdaq Capital Market's minimum bid price continued listing requirement. The letter noted that, as of April 14, 2026, the Company evidenced a closing bid price of its common stock in excess of the $1.00 minimum requirement for the last 10 consecutive trading days. Accordingly, the Company has regained compliance with Nasdaq Marketplace Rule 5550(a)(2) and Nasdaq
- INSIDERSEC Form 4 filed by Frank Morgan C.4 - Modular Medical, Inc. (0001074871) (Issuer)
- NEWSModular Medical Receives FDA 510(k) Clearance for Pivot Tubeless Insulin Patch PumpFirst Removable 2-Part Design Targets $3 Billion "Almost-Pumper" Market with Expected Q2 2026 initial deployment.Key Milestones & Investment Highlights:FDA 510(k) Clearance Achieved: Pivot™ pump now cleared for commercial sale in the U.S. - major de-risking event unlocking revenue path.First-in-Class Removable Tubeless Patch Pump: 3 mL detachable reservoir; no battery recharging required; removable for showering, sports or discretion; quick bolus button without a separate controller.Targets Massive Underserved Market: ~70% of insulin-dependent adults remain on multiple daily injections (MDI) due to complexity, cumbersomeness and cost - Pivot addresses the "3 Cs" for "almost-pumpers" with its
- INSIDERSEC Form 4 filed by Vos Ellen O'Connor4 - Modular Medical, Inc. (0001074871) (Issuer)
- INSIDERSEC Form 4 filed by Goldberg Jeff D4 - Modular Medical, Inc. (0001074871) (Issuer)
- INSIDERSEC Form 4 filed by Sheibley Philip Brent4 - Modular Medical, Inc. (0001074871) (Issuer)
- INSIDERSEC Form 4 filed by Felsher Steven G4 - Modular Medical, Inc. (0001074871) (Issuer)
- INSIDERSEC Form 4 filed by Desisto Duane M4 - Modular Medical, Inc. (0001074871) (Issuer)
- INSIDERSEC Form 4 filed by Volkart Carmen B4 - Modular Medical, Inc. (0001074871) (Issuer)
- SECModular Medical Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits8-K - Modular Medical, Inc. (0001074871) (Filer)
- NEWSModular Medical Announces 1-for-30 Reverse Stock SplitSAN DIEGO, CA / ACCESS Newswire / March 26, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), an innovative insulin delivery technology company, today announced that it will effect a 1-for-30 reverse stock split of its outstanding common stock. The reverse stock split will become effective at 5:30am ET on March 31, 2026. The common stock is expected to begin trading on a split-adjusted basis on the Nasdaq Capital Market ("Nasdaq") under the same symbol "MODD" when the market opens on March 31, 2026, with the new CUSIP number 60785L306.The reverse stock split was approved by the Company's shareholders at the Company's fiscal 2026 Annual Meeting, held on January
- SECSEC Form S-8 filed by Modular Medical Inc.S-8 - Modular Medical, Inc. (0001074871) (Filer)
- SECModular Medical Inc. filed SEC Form 8-K: Other Events8-K - Modular Medical, Inc. (0001074871) (Filer)
- SECModular Medical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Modular Medical, Inc. (0001074871) (Filer)
MODD FAQ
5 questionsWhat does Modular Medical Inc. do?
Modular Medical, Inc., a development stage medical device company, focuses on the design, development, and commercialization of insulin pumps using technology to enhance pump adoption in the diabetes marketplace. The company is headquartered in San Diego, California.Where does MODD stock trade?
Modular Medical Inc. (MODD) is listed on NASDAQ.What sector and industry is MODD in?
Modular Medical Inc. operates in the Health Care sector, Medical/Dental Instruments industry.What companies are similar to MODD?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare MODD side-by-side with any of them on Quantisnow.How can I track MODD on Quantisnow?
Quantisnow aggregates Modular Medical Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MODD to receive live email and push alerts on every new disclosure.